Expiring patents of major branded products has paved a way for generics, which is expected to stimulate growth of the Europe pharmaceutical drugs market during the forecast period.
In the near future, the pharmaceutical drugs market is expected to experience a robust growth due to expiring patents of key pharmaceutical products. Generic products offer better affordability and have priced economically. Numerous organizations are launching these products globally, hence accounting for rise in sales which has created potential opportunities for companies in distribution of low cost drugs. Erbitux (Cetuximab) is an epidermal growth factor receptor inhibitor developed for treating neck cancer, head cancer, and metastatic colorectal cancer. It is developed under the patent by Eli Lily Company and Bristol-Myers Squibb in the European region. The patent of this drug had expired in 2018, and is expected to offer lucrative opportunity for several companies operating in the market.
Get Sample Report with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-sample/3541
Moreover, rising M&A among key players is expected to boost growth of the Europe pharmaceutical drugs market over the forecast period. In August 2018, Novo Nordisk had acquired Ziylo, a British diabetic drug provider. This deal is poised to enhance the product portfolio of the later for diabetes therapeutics.
Rising prevalence of chronic diseases is expected to fuel growth of the Europe pharmaceutical drugs market. Recently, there has been a rise in diabetic patients in the Europe, which is poised to stimulate demand for generic and branded drugs. In 2019, as per the report from the International Diabetes Federation, cases of diabetes are projected to rise from 6.3% in 2019 to about 7.8% by 2045.
The focus of major companies in the market on adopting strategy of M&A to broaden their geographical reach and portfolio of products in the Europe pharmaceutical drugs market. In January 2020, Boehringer Ingelheim had partnered with a British pharmacy organization, PhoreMost Limited to develop new therapies.
During the forecast period, the Europe pharmaceutical drugs market is projected to manifest a CAGR of 4.5%, due to rising prevalence of diseases and expenditure on M&As. In January 2019, Takeda Pharmaceutical Company Limited had merged with Shire plc. to increase former’s presence in the European market.
Get PDF Brochure with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-pdf/3541
According to type of drug: In 2018, the branded segment is projected to lead the Europe pharmaceutical drugs market due to rising incidences of chronic diseases and increased strategic collaborations. As per the 2017 report from the World Health Organization (WHO), about 10% of men and almost 9% of women aging 25+ years were diagnosed with diabetes.
According to type of product: Over the forecast period, the prescription segment is anticipated to grow at a higher CAGR due to rising strategic deals among key players to increase their presence in the marketplace. In December 2019, GlaxoSmithKline had made an agreement with Pfizer Inc., to integrate their units of consumer healthcare with formation of mutual venture to enhance prescription drugs.
According to application: In 2019, the oncology segment is poised to hold a dominating position in the Europe pharmaceutical drugs market due to rising number of patients. In 2018, as per the report from the World Health Organization (WHO), European women are most commonly affected with cervical cancer with around 69,000 reports of newer cases each year. Hence, rising number of patients is expected to fuel growth of the Europe pharmaceutical drugs market over the forecast period.
Key companies contributing in the Europe pharmaceutical drugs market are Merck KGaA, Baxter AG, Boehringer Ingelheim, Allergan plc., Sanofi, Novo Nordisk, AstraZeneca Plc., F. Hoffmann-La Roche Ltd, Shire, Novartis AG, and GlaxoSmithKline Plc.
Reasons to Purchase this Report
• Current and future of Europe Pharmaceutical Drugs market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Product Type
- Market Snippet, By Application
- Market Snippet, By Distribution Channel
- Market Snippet, By Country/Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Developments
- Industry Trends
- Regulatory Scenario
- Reimbursement Scenario
- Epidemiology
- PEST Analysis
- Market Dynamics
- Europe Pharmaceutical Drugs Market, By Drug Type, 2019 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Generic Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Branded Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
- Europe Pharmaceutical Drugs Market, By Product Type, 2019 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Prescription Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Over-the-counter (OTC) Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
- Europe Pharmaceutical Drugs Market, By Application, 2019 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Cardiovascular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Musculoskeletal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Anti-infective
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Metabolic Disorder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Central Nervous System
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Genito-urinary
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Gastrointestinal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Respiratory
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Hematology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Dermatology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Ophthalmology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
- Europe Pharmaceutical Drugs Market, By Distribution Channel, 2019 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
- Europe Pharmaceutical Drugs Market, By Country, 2019 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2026
- U.K.
- Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Germany
- Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- France
- Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Italy
- Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Spain
- Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Russia
- Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Netherlands
- Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Poland
- Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Switzerland
- Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Sweden
- Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Rest of Europe
- Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Introduction
- Competitive Landscape
- Company Profiles
- Allergan plc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Novo Nordisk
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Boehringer Ingelheim
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Merck KGaA
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- GlaxoSmithKline Plc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- AstraZeneca Plc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Baxter AG
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Novartis AG
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- F. Hoffmann-La Roche Ltd
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Shire
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Sanofi
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Allergan plc.
- Company Profiles
- Section
- References
- Research Methodology
- About us and Sales Contact
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837